Bonavina Luigi
Division of General and Foregut Surgery, Department of Biomedical Sciences for Health, University of Milan, IRCCS Policlinico San Donato, San Donato Milanese (Milano), Italy.
Ann Transl Med. 2021 May;9(10):907. doi: 10.21037/atm.2020.03.66.
The esophagogastric anastomosis is most commonly performed to restore digestive tract continuity after esophagectomy for cancer. Despite a long history of clinical research and development of high-tech staplers, this procedure is still feared by most surgeons and associated with a 10% leakage rate. Among specific factors that may contribute to failure of the esophageal anastomosis are the absence of serosa layer, longitudinal orientation of muscle fibers, and ischemia of the gastric conduit. It has recently been suggested that the gut microbiome may influence the healing process of the anastomosis through the presence of collagenolytic bacterial strains, indicating that suture breakdown is not only a matter of collagen biosynthesis. The esophagogastric anastomosis can be performed either in the chest or neck, and can be completely hand-sewn, completely stapled (circular or linear stapler), or semi-mechanical (linear stapler posterior wall and hand-sewn anterior wall). Because of the lack of randomized clinical trials, no conclusive evidence is available, and the debate between the hand-sewn and the stapling technique is still ongoing even in the present era of robotic surgery. Centralization of care has improved the overall postoperative outcomes of esophagectomy, but the esophagogastric anastomosis remains the Achille's heel of the procedure. More research and network collaboration of experts is needed to improve safety and clinical outcomes.
食管胃吻合术最常用于食管癌切除术后恢复消化道连续性。尽管临床研究历史悠久且高科技吻合器不断发展,但该手术仍令大多数外科医生畏惧,且吻合口漏发生率达10%。可能导致食管吻合失败的具体因素包括缺乏浆膜层、肌纤维纵向排列以及胃管缺血。最近有研究表明,肠道微生物群可能通过存在胶原olytic菌株影响吻合口愈合过程,这表明缝线断裂不仅是胶原生物合成的问题。食管胃吻合术可在胸部或颈部进行,可完全手工缝合、完全用吻合器(圆形或线性吻合器),或半机械方式(后壁用线性吻合器,前壁手工缝合)。由于缺乏随机临床试验,尚无确凿证据,即使在当今机器人手术时代,手工缝合与吻合器技术之间的争论仍在继续。医疗集中化改善了食管癌切除术后的总体结局,但食管胃吻合术仍是该手术的致命弱点。需要更多研究和专家网络合作以提高安全性和临床结局。